儿科肠衰竭与血管通路。

Pediatric intestinal failure and vascular access.

机构信息

Department of Surgery and Center for Advanced Intestinal Failure, Children's Hospital Boston and Harvard Medical School, Fegan 3, 300 Longwood Avenue, Boston, MA 02115, USA.

出版信息

Surg Clin North Am. 2012 Jun;92(3):729-43, x. doi: 10.1016/j.suc.2012.03.012.

DOI:10.1016/j.suc.2012.03.012

PMID:22595718

Abstract

Emerging developments in the care of intestinal failure (IF) patients have drastically improved their overall prognosis, with recently reported survival rates over 90%. IF patients remain an extremely complex population who benefit from specialized, multidisciplinary care. Advances in the provision of parenteral and enteral nutrition, progress in the management of IF-associated liver disease with parenteral fish oil and catheter-associated blood stream infection with ethanol lock therapy, and the availability of novel surgical interventions, such as the serial transverse enteroplasty procedure, have made this a dynamic health care field with the promise of ongoing improvements in outcomes for these patients.

摘要

肠衰竭（IF）患者的护理方面出现了新的发展，极大地改善了他们的整体预后，最近报道的生存率超过 90%。IF 患者仍然是一个极其复杂的群体，他们受益于专门的多学科护理。肠外和肠内营养的提供方面的进步、用鱼油治疗 IF 相关肝病和乙醇封管疗法治疗导管相关血流感染方面的进展，以及新型手术干预措施（如序贯横向肠成形术）的应用，使这一领域成为一个充满活力的医疗保健领域，这些患者的治疗效果有望持续改善。